CTOs on the Move

MPI Research

www.mpiresearch.com

 
MPI Research, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. MPI Research, Inc. is based in Mattawan, MI. You can find more information on MPI Research, Inc. at www.mpiresearch.com
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Sybron Dental Specialties, Inc.

Sybron Dental Specialties, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Anaheim, CA. To find more information about Sybron Dental Specialties, Inc., please visit www.sybrondental.com

Stafford Suites

Stafford Suites is a Sumner, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TestZone

TestZone is a global health security provider of multi-layered screening programs to keep spaces safer. Founded by internationally recognized experts in medical diagnostics and public health, we create customizable, on-site solutions for any institution or business that needs to keep its doors open by keeping its people healthy amid always evolving health threats.

Parkview Imaging Open M R I

Parkview Imaging Open M R I is a Santa Monica, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Xenon Pharmateuticals

Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b “X-TOLE” study in adult patients with focal epilepsy. We are also proud of the leading-edge science coming out of our discovery labs, with many early-stage research programs underway. In addition to Xenon`s proprietary programs, we have ongoing collaborations with our valued pharmaceutical partners. With a healthy balance sheet to support our growth plans, we continue to build a fully-integrated, premier neuroscience company with strong discovery, development, and commercial operations. Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver new medicines for patients in need. Building and maintaining a respectful, collaborative, inclusive, and productive culture is a priority for us. We are looking for great people who thrive in a fast-paced, dynamic work environment to join our team during this transformative time for Xenon.